Cite
HARVARD Citation
Giallongo, C. et al. (2018). Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib. Journal of cellular and molecular medicine. 22 (2), pp. 1070-1080. [Online].